Cytek Biosciences, Inc.
CTKB
$4.81
$0.153.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 262.00M | 262.23M | 261.53M | 261.73M | 262.02M |
| Total Receivables | 51.30M | 56.48M | 72.13M | 61.67M | 56.67M |
| Inventory | 53.11M | 50.38M | 48.66M | 51.91M | 49.94M |
| Prepaid Expenses | 3.25M | 3.84M | 6.90M | 2.85M | 4.03M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 8.27M | 6.37M | 2.79M | 10.32M | 10.17M |
| Total Current Assets | 377.93M | 379.30M | 392.00M | 388.49M | 382.83M |
|
|
|||||
| Total Current Assets | 377.93M | 379.30M | 392.00M | 388.49M | 382.83M |
| Net Property, Plant & Equipment | 31.76M | 31.11M | 29.32M | 29.20M | 34.74M |
| Long-term Investments | 16.69M | 16.69M | 16.70M | 16.70M | 16.71M |
| Goodwill | 16.69M | 16.69M | 16.70M | 16.70M | 16.71M |
| Total Other Intangibles | 14.87M | 15.70M | 16.82M | 17.68M | 18.60M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.69M | 4.71M | 5.10M | 41.25M | 38.85M |
| Total Assets | 446.93M | 449.11M | 461.54M | 494.92M | 493.32M |
|
|
|||||
| Total Accounts Payable | 8.41M | 6.74M | 6.41M | 7.63M | 6.85M |
| Total Accrued Expenses | 25.43M | 21.59M | 25.18M | 21.68M | 22.12M |
| Short-term Debt | 8.83M | 10.11M | 5.70M | 600.00K | 1.40M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.87M | 3.54M | 3.48M | 10.08M | 7.37M |
| Total Finance Division Other Current Liabilities | 37.81M | 38.95M | 37.04M | 35.22M | 35.53M |
| Total Other Current Liabilities | 37.81M | 38.95M | 37.04M | 35.22M | 35.53M |
| Total Current Liabilities | 84.34M | 80.94M | 77.80M | 75.21M | 73.27M |
|
|
|||||
| Total Current Liabilities | 84.34M | 80.94M | 77.80M | 75.21M | 73.27M |
| Long-Term Debt | 246.00K | 386.00K | 525.00K | 655.00K | 791.00K |
| Short-term Debt | 8.83M | 10.11M | 5.70M | 600.00K | 1.40M |
| Capital Leases | 13.52M | 13.44M | 14.04M | 13.49M | 14.12M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 26.88M | 26.71M | 27.43M | 26.99M | 27.58M |
| Total Liabilities | 124.98M | 121.47M | 119.80M | 116.35M | 115.76M |
|
|
|||||
| Common Stock & APIC | 451.98M | 445.88M | 441.24M | 435.41M | 429.78M |
| Retained Earnings | -132.76M | -120.60M | -101.74M | -57.66M | -52.18M |
| Treasury Stock & Other | 2.74M | 2.37M | 2.24M | 821.00K | -38.00K |
| Total Common Equity | 321.95M | 327.64M | 341.74M | 378.57M | 377.56M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 321.95M | 327.64M | 341.74M | 378.57M | 377.56M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 321.95M | 327.64M | 341.74M | 378.57M | 377.56M |
|
|
|||||